Moderna takes HIV trimer mRNA vaccine into clinical trials

The first participant has been dosed in a Phase 1 clinical trial of HIV trimer mRNA vaccine candidate mRNA-1574.

HTTPS://WWW.BIOPHARMA-REPORTER.COM/ARTICLE/2022/03/14/MODERNA-TAKES-MRNA-HIV-CANDIDATE-INTO-CLINICAL-TRIALS